PodcastIntel
Sign in Get Started Free
The Long Run with Luke Timmerman
The Long Run with Luke Timmerman

Ep21: Tony Coles

Jun 21, 2018 · 01:01:57
Listen to Episode
✨ AI Summary
  • Tony Coles discusses neurodegenerative drug discovery.
  • Emphasizes the importance of inclusive leadership.
  • Key takeaway: Diversity fuels innovation in drug development.

Guests on This Episode

TC
Tony Coles
American doctor, businessperson and board member, Executive Chairman and Chief Executive Officer, Cerevel Therapeutics LLC; Member, Board of Directors, Council on Foreign Relations · 1 podcast appearance
›

More from The Long Run with Luke Timmerman

The Long Run with Luke Timmerman
Ep211: Ardem Patapoutian on Touch, Pain & New Discoveries in Neuroscience
Oct 7, 2026 · 01:06:37
The Long Run with Luke Timmerman
Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders
Sep 23, 2026 · 01:03:57
The Long Run with Luke Timmerman
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Sep 9, 2026 · 01:36:12
The Long Run with Luke Timmerman
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
Aug 25, 2026 · 01:07:17
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to The Long Run with Luke Timmerman and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →